// App-Quantinova.ai

927 : Fibroblast-induced switching to the invasive phenotype and PI3K-mTOR signaling protects melanoma cells from BRAF inhibitors

Researchers

Presenter

  • Kotryna Seip

Principal Investigators

  • Karianne Giller Fleten

  • Anna Barkovskaya

  • Vigdis Nygaard

  • Mads Haugen Haugen

  • Birgit vsteb Engester

  • Gunhild Mari Mlandsmo

  • Lina Prasmickaite

Medical Centers

  • Dept. of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway

Locations

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved